Processing

Please wait...

Settings

Settings

1. WO2000043023 - PHARMACEUTICAL COMPOSITION WITH ADHESION MOLECULE EXPRESSION REGULATING ACTIVITY

Publication Number WO/2000/043023
Publication Date 27.07.2000
International Application No. PCT/ES2000/000026
International Filing Date 21.01.2000
Chapter 2 Demand Filed 09.08.2000
IPC
A61P 25/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61P 37/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
A61P 43/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
CPC
A61K 36/11
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
11Pteridophyta or Filicophyta (ferns)
A61P 25/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
A61P 37/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applicants
  • ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A. [ES/ES]; Sagitario, 14 E-03006 Alicante, ES (AllExceptUS)
  • QUINTANILLA ALMAGRO, Eliseo [ES/ES]; ES (UsOnly)
  • DIAZ ALPERI, Joaquín [ES/ES]; ES (UsOnly)
Inventors
  • QUINTANILLA ALMAGRO, Eliseo; ES
  • DIAZ ALPERI, Joaquín; ES
Agents
  • SEMPERE MASSA, Iván, Luís; Bazán, 20, 6º, Ofic. 606 E-03001 Alicante, ES
Priority Data
P 990018225.01.1999ES
Publication Language Spanish (ES)
Filing Language Spanish (ES)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION WITH ADHESION MOLECULE EXPRESSION REGULATING ACTIVITY
(ES) UNA COMPOSICION FARMACEUTICA CON ACTIVIDAD REGULADORA DE LA EXPRESION DE LAS MOLECULAS DE ADHESION
(FR) COMPOSITION PHARMACEUTIQUE A ACTIVITE REGULATRICE DE L'EXPRESSION DES MOLECULES
Abstract
(EN)
The invention relates to a novel pharmacological application of a pharmaceutical composition exhibiting regulating activity of the expression of adhesion molecules integrins, selectins and immunoglobulins and its application as anti-inflammatory agent. Said pharmaceutical composition contains Anapsos, a water-soluble extract and a lipo-soluble extract of the rhizomes of Polypodium leucotomos as active substance in addition to acceptable excipients.
(ES)
Una nueva aplicación farmacológica de una composición farmacéutica con actividad reguladora de la expresión de las moléculas de adhesión, integrinas, selectinas e inmunoglobulinas y su aplicación como agente antiinflamatorio. Esta composición farmacéutica contiene como principio activo el Anapsos un extracto hidrosoluble y un extracto liposoluble de los rizomas de Polypodium leucotomos, junto a excipientes aceptables.
(FR)
L'invention concerne une nouvelle application pharmacologique d'une composition pharmaceutique activité à régulatrice de l'expression des molécules d'adhésion, des intégrines, des sélectines et des immunoglobulines ainsi que son application en tant qu'agent anti-inflammatoire. Cette composition pharmaceutique contient, comme principe actif, l'Anapsos, un extrait hydrosoluble et un extrait liposoluble des rhizomes de Polypodium leucotomos, conjointement avec des excipients acceptables.
Also published as
Latest bibliographic data on file with the International Bureau